Literature DB >> 27573344

[Lymph node dissection in sentinel lymph node-positive malignant melanoma].

K Welsch1, A S Yazdi2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27573344     DOI: 10.1007/s00105-016-3869-0

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  3 in total

1.  Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma".

Authors:  Annette Pflugfelder; Corinna Kochs; Andreas Blum; Marcus Capellaro; Christina Czeschik; Therese Dettenborn; Dorothee Dill; Edgar Dippel; Thomas Eigentler; Petra Feyer; Markus Follmann; Bernhard Frerich; Maria-Katharina Ganten; Jan Gärtner; Ralf Gutzmer; Jessica Hassel; Axel Hauschild; Peter Hohenberger; Jutta Hübner; Martin Kaatz; Ulrich R Kleeberg; Oliver Kölbl; Rolf-Dieter Kortmann; Albrecht Krause-Bergmann; Peter Kurschat; Ulrike Leiter; Hartmut Link; Carmen Loquai; Christoph Löser; Andreas Mackensen; Friedegund Meier; Peter Mohr; Matthias Möhrle; Dorothee Nashan; Sven Reske; Christian Rose; Christian Sander; Imke Satzger; Meinhard Schiller; Heinz-Peter Schlemmer; Gerhard Strittmatter; Cord Sunderkötter; Lothar Swoboda; Uwe Trefzer; Raymond Voltz; Dirk Vordermark; Michael Weichenthal; Andreas Werner; Simone Wesselmann; Ansgar J Weyergraf; Wolfgang Wick; Claus Garbe; Dirk Schadendorf
Journal:  J Dtsch Dermatol Ges       Date:  2013-08       Impact factor: 5.584

2.  Long-term follow-up confirms the oncologic safety of sentinel node biopsy without axillary dissection in node-negative breast cancer patients.

Authors:  Armando E Giuliano; Alice P Chung
Journal:  Ann Surg       Date:  2010-04       Impact factor: 12.969

3.  Complete lymph node dissection in melanoma.

Authors:  Charlotte Ariyan
Journal:  Lancet Oncol       Date:  2016-05-05       Impact factor: 41.316

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.